Sarah Cannon/CBCI is a clinical research site located in Denver, Colorado, United States 80218.
Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.
Sarah Cannon/CBCI has participated in 1 clinical trials.
Therapeutic areas: Leukemia.
Sponsors: Takeda.
Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Sarah Cannon/CBCI has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Sarah Cannon/CBCI has 1 clinical trials on record. Their work covers Leukemia.
Sarah Cannon/CBCI has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.